Okyo Pharma Limited (OKYO.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 09-2022 | 03-2022 | 09-2021 | 03-2021 | 09-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 708 | 2,701 | 5,169 | 6,861 | 7,412 |
| Receivables | 540 | 883 | 315 | 76 | 50 |
| TOTAL | $1,769 | $4,295 | $5,523 | $6,958 | $7,483 |
| Non-Current Assets | |||||
| PPE Net | 6 | 5 | 86 | 104 | 30 |
| TOTAL | $6 | $5 | $86 | $104 | $30 |
| Total Assets | $1,774 | $4,301 | $5,608 | $7,062 | $7,513 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,523 | 742 | 216 | 210 | 332 |
| Accrued Expenses | 471 | 564 | 339 | 1,456 | 36 |
| TOTAL | $2,120 | $1,353 | $617 | $1,700 | $417 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $47 | $64 | $24 |
| Total Liabilities | $2,120 | $1,353 | $664 | $1,765 | $441 |
| Shareholders' Equity | |||||
| Common Shares | 87,847 | 123,977 | 102,543 | 0 | 86,363 |
| Retained earnings | -90,904 | -112,426 | -99,968 | -99,768 | -90,555 |
| Other shareholders' equity | 2,710 | -8,603 | 2,369 | 12,770 | 11,264 |
| TOTAL | $-346 | $2,947 | $4,944 | $5,298 | $7,072 |
| Total Liabilities And Equity | $1,774 | $4,301 | $5,608 | $7,062 | $7,513 |